4//SEC Filing
Weisman Wayne 4
Accession 0001062993-22-015122
CIK 0001780097other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:10 PM ET
Size
5.0 KB
Accession
0001062993-22-015122
Insider Transaction Report
Form 4
Baudax Bio, Inc.BXRX
Weisman Wayne
Director
Transactions
- Award
Common Stock
2022-06-15+39,473→ 42,900 total
Footnotes (1)
- [F1]Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date.
Issuer
Baudax Bio, Inc.
CIK 0001780097
Entity typeother
Related Parties
1- filerCIK 0001602327
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:10 PM ET
- Size
- 5.0 KB